Anti-oxidant therapy in non-alcoholic fatty liver disease: the role of silymarin

被引：32

作者：

Abenavoli, Ludovico ^{[1
]}

Milic, Natasa ^{[2
]}

Capasso, Francesco ^{[3
]}

机构：

[1] Magna Graecia Univ Catanzaro, Dept Hlth Sci, I-88100 Catanzaro, Italy

[2] Univ Novi Sad, Dept Pharm, Novi Sad 21000, Serbia

[3] Univ Naples Federico II, Dept Expt Pharmacol, I-80131 Naples, Italy

来源：

ENDOCRINE | 2012年 / 42卷 / 03期

关键词：

Insulin Resistance; Silymarin; Free Fatty Acid Level; Silibinin; Favorable Safety Profile;

D O I：

10.1007/s12020-012-9677-0

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：754 / 755

页数：2

共 5 条

[1]

Role of silymarin to treat fibrosis development in non-alcoholic fatty liver disease [J].

Abenavoli, Ludovico .

HEPATOLOGY RESEARCH, 2011, 41 (07) :668-668

[2]

Role of adipocytokines in predicting the development of diabetes and its late complications [J].

Gulcelik, Nese Ersoz ;

Usman, Aydan ;

Gurlek, Alper .

ENDOCRINE, 2009, 36 (03) :397-403

[3]

Non-alcoholic fatty liver disease and cardiovascular risk: metabolic aspects and novel treatments [J].

Scorletti, E. ;

Calder, P. C. ;

Byrne, C. D. .

ENDOCRINE, 2011, 40 (03) :332-343

[4]

Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice [J].

Volti, Giovanni Li ;

Salomone, Salvatore ;

Sorrenti, Valeria ;

Mangiameli, Andrea ;

Urso, Vincenzo ;

Siarkos, Ilias ;

Galvano, Fabio ;

Salamone, Federico .

CARDIOVASCULAR DIABETOLOGY, 2011, 10

[5]

Coexistence of non-alcoholic fatty liver disease with elevated alanine aminotransferase is associated with insulin resistance in young Han males [J].

Wang, Rui ;

Lu, Qiang ;

Feng, Ji ;

Yin, Fuzai ;

Qin, Chunmei ;

Liu, Bo ;

Liu, Yali ;

Liu, Xiaoli .

ENDOCRINE, 2012, 41 (01) :70-75

← 1 →